June 14, 2001 — IRVING, TX — Carrington Laboratories has established a new development unit that will focus on high-end products from medical devices to nutraceuticals. The team will act either independently or as an extension of client’s research and development teams.
Carington Laboratories is an ISO 9011-ceertified, research-based biopharmaceuticals company, a distinction officials are proud of.
“Carrington, to my knowledge, is the only company with ISO 9001 certification, cGMP facilities and a dedicated research and development team making its services available to the industry,” said G. Scott Vogel, vice president of operations. “Through our vertical integration of research, raw materials, formulations, manufacturing and packaging, we can develop a line of products from concept through delivery to customers that will meet or exceed all regional, national or international standards.”
The company is currently upgrading its equipment and adding specialized labeling and language capabilities. All of the products will be developed in Carrington’s facilities in Texas and Costa Rica.